Cognition Therapeutics: A High-Stakes Bet On A Single Drug - Why I Hold
Source: SeekingAlpha
2025-11-21 19:54:22 ET
Read the full article on Seeking Alpha
For further details see:
Cognition Therapeutics: A High-Stakes Bet On A Single Drug - Why I Hold
Cognition Therapeutics Inc.
NASDAQ: CGTX
CGTX Trading
-5.28% G/L:
$1.07 Last:
274,586 Volume:
$1.12 Open:
CGTX Latest News
March 02, 2026 07:30:00 am
Cognition Therapeutics Advancing Zervimesine (CT1812) for Dementia with Lewy Bodies (DLB) Psychosis
February 05, 2026 07:30:00 am
Cognition Therapeutics Extends Expanded Access Program for Zervimesine (CT1812) in Dementia with Lewy Bodies
January 27, 2026 07:30:00 am
Cognition Therapeutics Completes Type C Meeting with FDA for Zervimesine (CT1812) in Dementia with Lewy Bodies
CGTX Stock Data
$101,508,290
75,557,475
3.63%
62
N/A
Biotechnology & Life Sciences
Healthcare
US
Purchase
